ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Starlink
|
52 |
8.5K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
52
|
8.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Starlink
|
52 |
8.5K |
1 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
52
|
8.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Starlink
|
52 |
8.5K |
0 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
52
|
8.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Starlink
|
52 |
8.5K |
0 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
52
|
8.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Starlink
|
52 |
8.5K |
0 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
52
|
8.5K
|
0
|
|
ASX - By Stock
|
SPL |
Nasal hygiene is a buzzing in US Spring
|
|
Starlink
|
0 |
162 |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
0
|
162
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Starlink
|
52 |
8.5K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
8.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Mundipharma and Astodrimer sodium
|
|
Starlink
|
2 |
756 |
0 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
2
|
756
|
0
|
|
ASX - By Stock
|
SPL |
Mundipharma and Astodrimer sodium
|
|
Starlink
|
2 |
756 |
3 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
2
|
756
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Starlink
|
29 |
5.3K |
3 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
29
|
5.3K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Starlink
|
29 |
5.3K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
29
|
5.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Starlink
|
29 |
5.3K |
1 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
29
|
5.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Starlink
|
29 |
5.3K |
4 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
29
|
5.3K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Starlink
|
29 |
5.3K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
29
|
5.3K
|
1
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
Starlink
|
53 |
12K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
53
|
12K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
Starlink
|
53 |
12K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
53
|
12K
|
1
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
Starlink
|
53 |
12K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
53
|
12K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Starlink
|
29 |
5.3K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
29
|
5.3K
|
1
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
Starlink
|
53 |
12K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
53
|
12K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Starlink
|
29 |
5.3K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
29
|
5.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Starlink
|
29 |
5.3K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
29
|
5.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
Starlink
|
29 |
5.3K |
5 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
29
|
5.3K
|
5
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
Starlink
|
53 |
12K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
53
|
12K
|
0
|
|
ASX - By Stock
|
SPL |
Could this happen to Viraleze with marketing approval
|
|
Starlink
|
29 |
5.3K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
29
|
5.3K
|
1
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
Starlink
|
53 |
12K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
53
|
12K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Why no SPL announcement on TGA decison
|
|
Starlink
|
13 |
2.2K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
2.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
Starlink
|
22 |
4.0K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
22
|
4.0K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Starlink
|
148 |
28K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
148
|
28K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
When multiple potential partners say yeah nah, not interested.
|
|
Starlink
|
29 |
5.4K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
29
|
5.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Big Pharma or Venture Capitalists
|
|
Starlink
|
19 |
2.6K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
19
|
2.6K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
New xxsbiz interview on Starpharma/Medicxi $38 million deal
|
|
Starlink
|
13 |
2.0K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
13
|
2.0K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
New xxsbiz interview on Starpharma/Medicxi $38 million deal
|
|
Starlink
|
13 |
2.0K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
13
|
2.0K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
New xxsbiz interview on Starpharma/Medicxi $38 million deal
|
|
Starlink
|
13 |
2.0K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
13
|
2.0K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Starlink
|
148 |
28K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
148
|
28K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification SPL Medicxi Partnership
|
|
Starlink
|
32 |
6.1K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
32
|
6.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification SPL Medicxi Partnership
|
|
Starlink
|
32 |
6.1K |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
32
|
6.1K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Starlink
|
148 |
28K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
28K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification SPL Medicxi Partnership
|
|
Starlink
|
32 |
6.1K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
32
|
6.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Starlink
|
148 |
28K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
28K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification SPL Medicxi Partnership
|
|
Starlink
|
32 |
6.1K |
2 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
32
|
6.1K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Starlink
|
148 |
28K |
2 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
28K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Starlink
|
148 |
28K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
28K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Starlink
|
148 |
28K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
28K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Starlink
|
148 |
28K |
7 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
28K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
Starlink
|
102 |
21K |
3 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
102
|
21K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
Starlink
|
102 |
21K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
102
|
21K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
Starlink
|
102 |
21K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
102
|
21K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
Starlink
|
102 |
21K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
102
|
21K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
Starlink
|
102 |
21K |
0 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
102
|
21K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Interim decision to amend the Poison Standard for astodrimer sodium
|
|
Starlink
|
32 |
7.5K |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
32
|
7.5K
|
2
|
|